RXDX
Morgan Stanley’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-390,276
| Closed | -$41.9M | – | 7758 |
|
|
2023
Q1 | $41.9M | Buy |
390,276
+231,910
| +146% | +$24.9M | ﹤0.01% | 1705 |
|
|
2022
Q4 | $17.4M | Sell |
158,366
-11,488
| -7% | -$1.26M | ﹤0.01% | 2484 |
|
|
2022
Q3 | $10M | Buy |
169,854
+38,662
| +29% | +$2.28M | ﹤0.01% | 2985 |
|
|
2022
Q2 | $3.7M | Buy |
131,192
+82,208
| +168% | +$2.32M | ﹤0.01% | 4019 |
|
|
2022
Q1 | $1.85M | Buy |
48,984
+36,704
| +299% | +$1.39M | ﹤0.01% | 4574 |
|
|
2021
Q4 | $486K | Buy |
12,280
+9,879
| +411% | +$391K | ﹤0.01% | 5565 |
|
|
2021
Q3 | $57K | Sell |
2,401
-455
| -16% | -$10.8K | ﹤0.01% | 6665 |
|
|
2021
Q2 | $71K | Buy |
2,856
+2,567
| +888% | +$63.8K | ﹤0.01% | 6508 |
|
|
2021
Q1 | $5K | Buy |
+289
| New | +$5K | ﹤0.01% | 7125 |
|